{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:52:15Z","timestamp":1788871935250,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Wellcome Trust Centre for Human Genetics","award":["090532\/Z\/09\/Z"],"award-info":[{"award-number":["090532\/Z\/09\/Z"]}]},{"name":"MRC Hub","award":["G0900747 91070"],"award-info":[{"award-number":["G0900747 91070"]}]},{"name":"National Institute for Health Research (NIHR) Oxford Biomedical Research Centre"},{"name":"European Union's Seventh Framework Programme","award":["279185"],"award-info":[{"award-number":["279185"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T20:00:18Z","timestamp":1398110418000},"page":"3424-3430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-9886","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.04.009_bib0005","series-title":"WHO practical guidelines","article-title":"Control of epidemic meningococcal disease","author":"WHO","year":"1998"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.009_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2807\/esm.10.12.00586-en","article-title":"Ascertainment of meningococcal disease in Europe","volume":"10","author":"Trotter","year":"2005","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.009_bib0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2014.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.04.009_bib0025","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2014.04.009_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0264-410X(02)00590-X","article-title":"Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine","volume":"21","author":"Salleras","year":"2003","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2014.04.009_bib0035","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1001\/jama.292.20.2491","article-title":"Effectiveness of a mass immunization campaign using serogroup C. meningococcal conjugate F vaccine","volume":"292","author":"De Wals","year":"2004","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.vaccine.2014.04.009_bib0040","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety immunogenicity induction of immunologic memory by a serogroup C. meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.009_bib0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.009_bib0050","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.009_bib0055","series-title":"Immunisation against infectious disease (the green book)","author":"Salisbury","year":"2013"},{"issue":"8","key":"10.1016\/j.vaccine.2014.04.009_bib0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1289\/ehp.01109757","article-title":"Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors","volume":"109","author":"Van Loveren","year":"2001","journal-title":"Environ Health Perspect"},{"issue":"9338","key":"10.1016\/j.vaccine.2014.04.009_bib0065","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins","volume":"360","author":"H\u00f6hler","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.009_bib0070","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2249.1993.tb03433.x","article-title":"The influence of genetic factors on the immune response as judged by pneumococcal vaccination of mono- and dizygotic Caucasian twins","volume":"92","author":"Konradsen","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"25","key":"10.1016\/j.vaccine.2014.04.009_bib0075","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1016\/j.vaccine.2006.04.021","article-title":"Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins","volume":"24","author":"Lee","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.009_bib0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2014.04.009_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin studies of immunogenicity \u2013 determining the genetic contribution to vaccine failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.009_bib0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/CVI.05379-11","article-title":"SNPs in the TLR3 and CD44 genes are associated with persistence of vaccine-induced immunity to serogroup C meningococcal conjugate vaccine","volume":"19","author":"Moore","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.009_bib0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/INF.0b013e318292f425","article-title":"Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom","volume":"32","author":"Blanchard-Rohner","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.009_bib0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/INF.0b013e31818e037d","article-title":"Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants","volume":"28","author":"Perrett","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.009_bib0105","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e31813429fa","article-title":"A new combination Haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants","volume":"26","author":"Pace","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2014.04.009_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.009_bib0115","first-page":"725","article-title":"Assignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992","volume":"9","author":"Elie","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2014.04.009_bib0120","article-title":"Amplification-refractory mutation system (ARMS) analysis of point mutations","author":"Little","year":"2001","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.vaccine.2014.04.009_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0212s60","article-title":"SNP genotyping using the Sequenom MassARRAY iPLEX platform","author":"Gabriel","year":"2009","journal-title":"Curr Protoc Hum Genet"},{"issue":"12","key":"10.1016\/j.vaccine.2014.04.009_bib0130","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"10.1016\/j.vaccine.2014.04.009_bib0135","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1093\/nar\/26.14.3404","article-title":"Automated detection of point mutations using fluorescent sequence trace subtraction","volume":"26","author":"Bonfield","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2014.04.009_bib0140","series-title":"R: a language and environment for statistical computing","author":"R core team","year":"2013"},{"issue":"7","key":"10.1016\/j.vaccine.2014.04.009_bib0145","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1371\/journal.pgen.0030114","article-title":"Imputation-based analysis of association studies: candidate regions and quantitative traits","volume":"3","author":"Servin","year":"2007","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.009_bib0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/502802","article-title":"A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase","volume":"78","author":"Scheet","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.vaccine.2014.04.009_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2014.04.009_bib0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1574-695X.2000.tb01460.x","article-title":"Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A\/C polysaccharide vaccine","volume":"28","author":"Borrow","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6857","key":"10.1016\/j.vaccine.2014.04.009_bib0165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.vaccine.2014.04.009_bib0170","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.vaccine.2008.01.017","article-title":"Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results","volume":"26","author":"Dhiman","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2014.04.009_bib0175","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1084\/jem.20081370","article-title":"TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events","volume":"205","author":"Cavassani","year":"2008","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2014.04.009_bib0180","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.137.5.1137","article-title":"An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function","volume":"137","author":"Weiss","year":"1997","journal-title":"J Cell Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.04.009_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"52","author":"Goodison","year":"1999","journal-title":"Mol Pathol"},{"issue":"8","key":"10.1016\/j.vaccine.2014.04.009_bib0190","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1371\/journal.pone.0012273","article-title":"Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis","volume":"5","author":"Ryckman","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:27Z","timestamp":1759400427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":38,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14005118"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}